Inhibitory effects of a standardized extract of Justicia pectoralis in an experimental rat model of airway hyper-responsiveness
- PMID: 28211571
- DOI: 10.1111/jphp.12689
Inhibitory effects of a standardized extract of Justicia pectoralis in an experimental rat model of airway hyper-responsiveness
Abstract
Objective: Justicia pectoralis is a plant useful for the treatment of respiratory diseases. Here, we studied the antiasthmatic properties of a standardized extract of J. pectoralis (Jp).
Methods: Ovalbumin (OVA)-sensitized rats were actively challenged with saline or OVA to study airway hyper-responsiveness after oral treatment with saline or Jp. The ability of Jp to inhibit hyper-reactivity was evaluated in isolated trachea mounted in isolated organ bath chamber.
Key findings: Using KCl or carbachol as contractile agents, tracheal rings of OVA-challenged rats contracted with higher magnitude than trachea of rats challenged with saline. Such hyper-responsive phenotype of OVA-challenged tissues decreased with Jp administration. In Ca+ -free medium, Jp or its major constituent coumarin inhibited preferentially the contractions induced by Ca2+ addition in tissues of OVA-challenged rats stimulated with KCl or acetylcholine. In tissues depleted of their internal Ca+ stores in the presence of thapsigargin, Jp inhibited the contraction induced by capacitative Ca2+ entry. By gavage, Jp abolished the increase caused by challenge with OVA on the levels of IL-1β and TNF-α in the bronchoalveolar fluid and also impaired the changes in gene expression of canonical transient receptor proteins.
Conclusions: Jp has antiasthmatic properties in an experimental model that reproduces tracheal hyper-reactivity.
Keywords: biological evaluation of natural products; tissue and cellular pharmacology.
© 2017 Royal Pharmaceutical Society.
Similar articles
-
Phytochemical study guided by the myorelaxant activity of the crude extract, fractions and constituent from stem bark of Hymenaea courbaril L.J Ethnopharmacol. 2013 Aug 26;149(1):62-9. doi: 10.1016/j.jep.2013.05.052. Epub 2013 Jun 10. J Ethnopharmacol. 2013. PMID: 23764737
-
Lipopolysaccharide inhibits the late-phase response to allergen by altering nitric oxide synthase activity and interleukin-10.Am J Respir Cell Mol Biol. 2001 May;24(5):640-6. doi: 10.1165/ajrcmb.24.5.4265. Am J Respir Cell Mol Biol. 2001. PMID: 11350836
-
Ocimum basilicum affects tracheal responsiveness, lung inflammatory cells and oxidant-antioxidant biomarkers in sensitized rats.Drug Chem Toxicol. 2019 May;42(3):286-294. doi: 10.1080/01480545.2018.1459672. Epub 2018 Apr 23. Drug Chem Toxicol. 2019. PMID: 29683006
-
Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens.J Allergy Clin Immunol. 2006 Aug;118(2):420-7. doi: 10.1016/j.jaci.2006.06.009. J Allergy Clin Immunol. 2006. PMID: 16890767
-
Panax ginseng ameliorates airway inflammation in an ovalbumin-sensitized mouse allergic asthma model.J Ethnopharmacol. 2011 Jun 14;136(1):230-5. doi: 10.1016/j.jep.2011.04.048. Epub 2011 Apr 28. J Ethnopharmacol. 2011. PMID: 21549818
Cited by
-
Overview of the Justicia Genus: Insights into Its Chemical Diversity and Biological Potential.Molecules. 2023 Jan 25;28(3):1190. doi: 10.3390/molecules28031190. Molecules. 2023. PMID: 36770856 Free PMC article. Review.
-
Organic Extract of Justicia pectoralis Jacq. Leaf Inhibits Interferon-γ Secretion and Has Bacteriostatic Activity against Acinetobacter baumannii and Klebsiella pneumoniae.Evid Based Complement Alternat Med. 2018 Aug 23;2018:5762368. doi: 10.1155/2018/5762368. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30210574 Free PMC article.
-
Use of Natural Products in Asthma Treatment.Evid Based Complement Alternat Med. 2020 Feb 13;2020:1021258. doi: 10.1155/2020/1021258. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32104188 Free PMC article. Review.
-
Evaluation of Gastroprotective Activity of the Methanolic Extract of Justicia pectoralis Jacq. (Acanthaceae).Nutrients. 2024 May 9;16(10):1430. doi: 10.3390/nu16101430. Nutrients. 2024. PMID: 38794668 Free PMC article.
-
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?Front Pharmacol. 2020 Sep 23;11:581840. doi: 10.3389/fphar.2020.581840. eCollection 2020. Front Pharmacol. 2020. PMID: 33071794 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous